For several years, Abcell-bio has been committed to its customers in order to facilitate their Research and Development projects. To go further, Abcell-bio has obtained the CIR agreement, which allows French companies to benefit from a tax credit on the expenses engaged in Research & Development or experimental procedures. It has been delivered by the French Ministry of Higher Education, Research & Innovation and it is valid for 3 years, until 2022. The basis for eligibility is an investment in research and development within the European Economic Area.
| Website | http://www.abcell-bio.com |
| Revenue | $5.8 million |
| Employees | View employees |
| Address | 5 Rue Henri Auguste Desbrures, Evry, Wallis and Futuna 91000, FR |
| Phone | +33 1 78 05 47 20 |
| Technologies |
HTML
,
Google Analytics
,
Google Tag Manager
+5 more
(view full list)
|
| Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
| Competitors | Novartis, Amgen, Intellia Therapeutics, Inc., CRISPR Therapeutics, bluebird bio, Rigel Pharmaceuticals Inc., Editas Medicine, Allogene Therapeutics, Caribou Biosciences, Cellectis +32 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular ABCell-Bio employee's phone or email?
ABCell-Bio Questions
The ABCell-Bio annual revenue was $5.8 million in 2026.
ABCell-Bio is based in Evry, Wallis and Futuna.
The NAICS codes for ABCell-Bio are [32541, 325414, 325, 32, 3254].
The SIC codes for ABCell-Bio are [283, 28].
Related Companies
